» Articles » PMID: 7644477

A Synthetic Inhibitor of the Mitogen-activated Protein Kinase Cascade

Overview
Specialty Science
Date 1995 Aug 15
PMID 7644477
Citations 590
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment of cells with a variety of growth factors triggers a phosphorylation cascade that leads to activation of mitogen-activated protein kinases (MAPKs, also called extracellular signal-regulated kinases, or ERKs). We have identified a synthetic inhibitor of the MAPK pathway. PD 098059 [2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one] selectively inhibited the MAPK-activating enzyme, MAPK/ERK kinase (MEK), without significant inhibitory activity of MAPK itself. Inhibition of MEK by PD 098059 prevented activation of MAPK and subsequent phosphorylation of MAPK substrates both in vitro and in intact cells. Moreover, PD 098059 inhibited stimulation of cell growth and reversed the phenotype of ras-transformed BALB 3T3 mouse fibroblasts and rat kidney cells. These results indicate that the MAPK pathway is essential for growth and maintenance of the ras-transformed phenotype. Further, PD 098059 is an invaluable tool that will help elucidate the role of the MAPK cascade in a variety of biological settings.

Citing Articles

Role of the androgen receptor in melanoma aggressiveness.

Di Donato M, Cristiani C, Capone M, Garofalo C, Madonna G, Passacatini L Cell Death Dis. 2025; 16(1):34.

PMID: 39837817 PMC: 11751086. DOI: 10.1038/s41419-025-07350-4.


Role of Rab13, Protein Kinase A, and Zonula Occludens-1 in Hepatitis E Virus Entry and Cell-to-Cell Spread: Comparative Analysis of Quasi-Enveloped and Non-Enveloped Forms.

Nagashima S, Primadharsini P, Takahashi M, Nishiyama T, Murata K, Okamoto H Pathogens. 2025; 13(12.

PMID: 39770389 PMC: 11678111. DOI: 10.3390/pathogens13121130.


EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer.

Zeng J, Wang C, Ruge F, Ji E, Martin T, Sanders A Sci Rep. 2024; 14(1):30850.

PMID: 39730634 PMC: 11680852. DOI: 10.1038/s41598-024-81485-w.


Molecular Dynamics Simulation on the Suppression Mechanism of Phosphorylation to Ser222 by Allosteric Inhibitors Targeting MEK1/2 Kinase.

Mudedla S, Lee H, Kim J, Jang S, Doddareddy M, Sanam S ACS Omega. 2024; 9(29):31946-31956.

PMID: 39072081 PMC: 11270731. DOI: 10.1021/acsomega.4c03615.


KRAS is a molecular determinant of platinum responsiveness in glioblastoma.

Zuchegna C, Leone S, Romano A, Porcellini A, Messina S BMC Cancer. 2024; 24(1):77.

PMID: 38225605 PMC: 10789061. DOI: 10.1186/s12885-023-11758-6.


References
1.
Ray L, Sturgill T . Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc Natl Acad Sci U S A. 1987; 84(6):1502-6. PMC: 304462. DOI: 10.1073/pnas.84.6.1502. View

2.
Pang L, Zheng C, Guan K, Saltiel A . Nerve growth factor stimulates a novel protein kinase in PC-12 cells that phosphorylates and activates mitogen-activated protein kinase kinase (MEK). Biochem J. 1995; 307 ( Pt 2):513-9. PMC: 1136678. DOI: 10.1042/bj3070513. View

3.
Ahn N, KREBS E . Evidence for an epidermal growth factor-stimulated protein kinase cascade in Swiss 3T3 cells. Activation of serine peptide kinase activity by myelin basic protein kinases in vitro. J Biol Chem. 1990; 265(20):11495-501. View

4.
Thomas S, DeMarco M, DArcangelo G, Halegoua S, Brugge J . Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell. 1992; 68(6):1031-40. DOI: 10.1016/0092-8674(92)90075-n. View

5.
Wood K, Sarnecki C, Roberts T, Blenis J . ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell. 1992; 68(6):1041-50. DOI: 10.1016/0092-8674(92)90076-o. View